| Product Code: ETC9214988 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Serbia Oncology NGS Market Overview |
3.1 Serbia Country Macro Economic Indicators |
3.2 Serbia Oncology NGS Market Revenues & Volume, 2021 & 2031F |
3.3 Serbia Oncology NGS Market - Industry Life Cycle |
3.4 Serbia Oncology NGS Market - Porter's Five Forces |
3.5 Serbia Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Serbia Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Serbia Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.8 Serbia Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.9 Serbia Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Serbia Oncology NGS Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Serbia |
4.2.2 Growing adoption of Next-Generation Sequencing (NGS) technology in oncology research |
4.2.3 Government initiatives and funding for cancer research and treatment |
4.3 Market Restraints |
4.3.1 High cost associated with NGS technology and testing |
4.3.2 Limited awareness and expertise in NGS technology among healthcare professionals in Serbia |
5 Serbia Oncology NGS Market Trends |
6 Serbia Oncology NGS Market, By Types |
6.1 Serbia Oncology NGS Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Serbia Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Serbia Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Serbia Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.2 Serbia Oncology NGS Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Serbia Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F |
6.2.3 Serbia Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F |
6.3 Serbia Oncology NGS Market, By Service |
6.3.1 Overview and Analysis |
6.3.2 Serbia Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F |
6.3.3 Serbia Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F |
6.4 Serbia Oncology NGS Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 Serbia Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F |
6.4.3 Serbia Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.4.4 Serbia Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F |
6.5 Serbia Oncology NGS Market, By End-use |
6.5.1 Overview and Analysis |
6.5.2 Serbia Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F |
6.5.3 Serbia Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F |
6.5.4 Serbia Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.5.5 Serbia Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F |
6.5.6 Serbia Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F |
7 Serbia Oncology NGS Market Import-Export Trade Statistics |
7.1 Serbia Oncology NGS Market Export to Major Countries |
7.2 Serbia Oncology NGS Market Imports from Major Countries |
8 Serbia Oncology NGS Market Key Performance Indicators |
8.1 Number of oncology NGS tests conducted annually in Serbia |
8.2 Adoption rate of NGS technology in oncology research and clinical practice |
8.3 Number of research studies and publications utilizing NGS technology in oncology in Serbia |
9 Serbia Oncology NGS Market - Opportunity Assessment |
9.1 Serbia Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Serbia Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Serbia Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F |
9.4 Serbia Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.5 Serbia Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Serbia Oncology NGS Market - Competitive Landscape |
10.1 Serbia Oncology NGS Market Revenue Share, By Companies, 2024 |
10.2 Serbia Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here